Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SLNO | SOLENO THERAPEUTICS INC | NASDAQ | Biotechnology | $2.04B | $39.49 | 6.76% | $28.99M | 98.73x | 0.25 | United States | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | NASDAQ | Biotechnology | $42.29B | $318.85 | -3.01% | $631.44M | 133.41x | 5.29 | United States | ||
| ADMA | ADMA BIOLOGICS INC | NASDAQ | Biotechnology | $2.19B | $9.19 | 0.88% | $197.86M | 14.82x | 0.31 | United States | ||
| ZVRA | ZEVRA THERAPEUTICS INC | NASDAQ | Biotechnology | $551.89M | $9.40 | -0.11% | $99.31M | 6.71x | 0.84 | United States | ||
| CORT | CORCEPT THERAPEUTICS INC | NASDAQ | Biotechnology | $4.52B | $42.49 | 1.21% | $45.21M | 44.73x | 0.29 | United States | ||
| ABEO | ABEONA THERAPEUTICS INC | NASDAQ | Biotechnology | $274.98M | $4.82 | 5.24% | $78.59M | 3.60x | 0.38 | United States | ||
| HALO | HALOZYME THERAPEUTICS INC | NASDAQ | Biotechnology | $7.61B | $64.49 | -1.39% | $573.05M | 24.43x | 50.73 | United States | ||
| KRYS | KRYSTAL BIOTECH INC | NASDAQ | Biotechnology | $7.63B | $260.95 | 0.79% | $196.02M | 36.86x | 0.09 | United States | ||
| RPRX | ROYALTY PHARMA PLC | NASDAQ | Biotechnology | $28.02B | $48.57 | 0.16% | $1.08B | 27.13x | 1.02 | United States | ||
| VCEL | VERICEL CORP | NASDAQ | Biotechnology | $1.73B | $34.14 | 4.85% | $34.90M | 103.45x | 0.38 | United States | ||
| NAGE | NIAGEN BIOSCIENCE INC | NASDAQ | Biotechnology | $350.75M | $4.38 | -3.10% | $19.64M | 19.91x | 0.39 | United States | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | NASDAQ | Biotechnology | $1.60B | $27.74 | -0.79% | $255.05M | 10.05x | 0.46 | United States | ||
| TECH | BIO-TECHNE CORP | NASDAQ | Biotechnology | $8.31B | $53.13 | -0.65% | $226.43M | 102.17x | 0.25 | United States | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | NASDAQ | Biotechnology | $10.67B | $55.50 | -3.04% | $572.94M | 30.49x | 0.25 | United States | ||
| APLS | APELLIS PHARMACEUTICALS INC | NASDAQ | Biotechnology | $5.17B | $40.41 | 0.05% | $70.00M | 224.50x | 1.91 | United States | ||
| MNKD | MANNKIND CORP | NASDAQ | Biotechnology | $770.25M | $2.50 | -1.57% | $52.93M | 125.00x | -16.53 | United States | ||
| EXEL | EXELIXIS INC | NASDAQ | Biotechnology | $11.40B | $43.88 | -0.36% | $994.49M | 15.24x | 0.32 | United States | ||
| CPRX | CATALYST PHARMACEUTICALS INC | NASDAQ | Biotechnology | $3.02B | $24.69 | -0.52% | $321.68M | 14.11x | 0.16 | United States | ||
| REGN | REGENERON PHARMACEUTICALS INC | NASDAQ | Biotechnology | $80.54B | $761.85 | -1.98% | $5.82B | 17.69x | 0.30 | United States | ||
| VCYT | VERACYTE INC | NASDAQ | Biotechnology | $2.56B | $32.25 | -0.46% | $92.61M | 38.39x | 0.07 | United States | ||
| LGND | LIGAND PHARMACEUTICALS INC | NASDAQ | Biotechnology | $3.98B | $199.59 | -0.02% | $199.39M | 30.99x | 0.53 | United States | ||
| VRTX | VERTEX PHARMACEUTICALS INC | NASDAQ | Biotechnology | $111.45B | $438.71 | -1.91% | $4.87B | 28.38x | 0.37 | United States | ||
| UTHR | UNITED THERAPEUTICS CORP | NASDAQ | Biotechnology | $24.75B | $564.81 | -0.96% | $1.82B | 18.75x | 0.11 | United States | ||
| XOMA | XOMA ROYALTY CORP | NASDAQ | Biotechnology | $392.65M | $32.98 | -0.30% | $34.69M | 21.56x | 2.01 | United States | ||
| INCY | INCYTE CORP | NASDAQ | Biotechnology | $19.09B | $95.93 | 1.73% | $1.76B | 14.56x | 0.35 | United States | ||
| CRMD | CORMEDIX INC | NASDAQ | Biotechnology | $557.31M | $7.05 | 0.43% | $167.35M | 3.13x | 1.04 | United States | ||
| MDXG | MIMEDX GROUP INC | NASDAQ | Biotechnology | $582.38M | $3.92 | -0.76% | $79.47M | 11.88x | 0.34 | United States |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.